Logo image
Prof. Dr. med. Tim H. Brummendorf working place, University Hospital Aachen
Prof. Dr. med. Tim H. Brummendorf
Excellent
AiroScore
9.80

Prof. Dr. med. Tim H. Brummendorf

hematology and oncology
hematology and oncology
User ScoreExperienceTotal ReviewsRatingPrice RangePublicationsOnline Consultations
95%29 years29.8/10$$$$494No

Overview

Country, City
Germany, Aachen
Health facility
University Hospital Aachen
Medical unit
Department of hematology, oncology, haemostaseology and stem cell transplantation with the center for integrated oncology
5.0 on Google
The data collected based on 2 patient reviews on Google

About the doctor

Prof. Dr. med. Tim H. Brummendorf is a renowned hematologist and oncologist with over 28 years of experience in the field. He obtained his medical degree from Heidelberg and Hamburg and completed his clinical training at the University Hospital in Tuebingen. In addition to his extensive education, Dr. Brummendorf has published 487 scientific publications, highlighting his expertise and commitment to advancing the field of hematology and oncology. Dr. Brummendorf is the founder and director of the Euroregional Comprehensive Oncology Center in Aachen, Germany. He also holds the director position in the Department of Hematology, Oncology, Haemostaseology, and Stem Cell Transplantation at the University Hospital Aachen. These leadership roles reflect his dedication to providing comprehensive and integrated care to patients seeking cancer and blood disorders treatment. Dr. Brummendorf's specialization in hematology and oncology and his active involvement in various professional organizations such as the Union for International Cancer Control and the American Society of Hematology highlight his commitment to staying at the forefront of advancements in the field. His research and clinical expertise make him an excellent choice for patients seeking comprehensive and cutting-edge treatment options for hematological and oncological conditions.

Skills & Expertise

leukemia
bosutinib
imatinib
cancer
neoplasms
myeloproliferative neoplasms
nilotinib
anemia
oncology
stem cell transplantation
hematology
hematopoietic stem cells
aplastic anemia
malignancies
bone marrow
dyskeratosis
myelogenous leukemia
lenalidomide
carcinoma
myeloid leukaemia
covid19
dasatinib
myelofibrosis
myeloma
lymphoblastic leukemia
gastrointestinal
prostate cancer
multiple myeloma
hemoglobinuria
mastocytosis
breast
systemic mastocytosis
polycythemia
polycythemia vera
myeloid malignancies
cell carcinoma
breast cancer
blood cells
dendritic cells
pancreatic cancer
colorectal cancer
stomach
gastric cancer
hepatocellular carcinoma
thrombocythemia
hodgkin lymphoma
neuroendocrine tumors
mammary carcinoma
pulmonary carcinosarcoma
squamouscell carcinoma

Resume

CV (Curriculum Vitae)

Education
  • 1988-1995 Studied medicine in Heidelberg and Hamburg
  • 1995 Defense of the dissertation
  • 1995 Obtaining a license for medical practice
  • 1995-1997 Clinical training at the University Hospital in Tuebingen
  • 1997-1999 Fellow of the German Research Foundation in Vancouver
  • 2003 Obtaining specialization in internal medicine
  • 2004 Habilitation and teaching license in internal medicine at the Tuebingen
  • 2007 Received additional specialization in hematology
  • 2007 Professor
Experience
  • 2005 University Hospital Hamburg-Eppendorf
  • Founded the University Oncology Center of Hamburg
  • 2009 Director, Department of hematology, oncology, haemostaseology and stem cell transplantation with the center for integrated oncology at the University Hospital Aachen
  • 2010 Founder and Director of the Euroregional Comprehensive Oncology Center Aachen
Awards & Memberships
  • Member of the German Research Foundation
  • Member of the Union for International Cancer Control
  • Member of the American Society of Hematology

Languages

English flag
English
German flag
German

Publications

Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study

August, 2023

P1004: ACTIVATING MUTATIONS IN JAK2 AND CALR DIFFERENTIALLY AFFECT INTRACELLULAR CALCIUM LEVELS AND CALCIUM FLUX

August, 2023

P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING

August, 2023

Location

Pauwelsstraße, 30, 52074 Aachen, Germany

FAQ

Where does the doctor practice?

What is the specialization of Prof. Dr. med. Tim H. Brummendorf?

The primary specialization of the doctor is hematology and oncology.

What is the experience of the specialist?

Prof. Dr. med. Tim H. Brummendorf has been practicing for more than 29 years.

What do patients say about Prof. Dr. med. Tim H. Brummendorf?

The doctor has 0 review on AiroMedical and and 2 feedbacks at other places. The UserScore of the specialist is 95%.

What is the rating of the doctor?

What topics does Prof. Dr. med. Tim H. Brummendorf expert at?

The doctor has excellent knowledge in leukemia, bosutinib, imatinib, cancer, neoplasms.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Prof. Dr. med. Tim H. Brummendorf doesn’t perform virtual appointments.

Prof. Dr. med. Tim H. Brummendorf
Prof. Dr. med. Tim H. Brummendorf

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. Tim H. Brummendorf

Similar Doctors

Excellent
AiroScore
9.80
University Hospital Aachen
pediatrics, pediatric hematology and oncology, pediatric gastroenterology and rheumatology
Excellent
AiroScore
10.00
University Hospital Charite Berlin
pediatrics, hematology, oncology, pediatric intensive care
Excellent
AiroScore
10.00
University Hospital Charite Berlin
haematology, oncology, leukaemia research, tumor immunology
Excellent
AiroScore
10.00
University Hospital Charite Berlin
gynecology, breast cancer, plastic, and reconstructive operations in gynecology
Excellent
AiroScore
10.00
University Hospital Charite Berlin
oncology, haematology, biological therapy of cancer
Excellent
AiroScore
9.90
University Hospital Heidelberg
pediatrics, pediatric hematology and oncology, pulmonology, and immunology
Excellent
AiroScore
9.90
University Hospital Tubingen
internal medicine, hematology, internal oncology and immunology
Excellent
AiroScore
9.90
University Hospital Halle (Saale)
internal medicine, oncology, and hematology
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, hematology, and oncology